The present invention relates generally to treatment of cardiac heart disease. More particularly, the present invention relates to implantable valve prostheses for implantation into the cardiac system.
All four of the valves in the heart are passive structures in that they do not themselves expend any energy and do not perform any active contractile function. They consist of moveable “leaflets” that open and close in response to differential pressures on either side of the valve. The problems that can develop with valves can generally be classified into two categories: (1) stenosis, in which a valve does not open properly, and (2) insufficiency (also called regurgitation), in which a valve does not close properly. Stenosis and insufficiency may occur concomitantly in the same valve or in different valves. Both of these abnormalities increase the workload placed on the heart. The severity of this increased stress on the heart and the patient, and the heart's ability to adapt to it, determine the treatment options that can be pursued. In some cases, medication can be sufficient to treat the patient, which is the preferred alternative; however, in many cases defective valves have to be repaired or completely replaced in order for the patient to live a normal life.
The two general categories of valves that are available for implantation into the cardiac system are mechanical valves and bioprosthetic or tissue valves. Mechanical valves have been used for many years and encompass a wide variety of designs that accommodate the blood flow requirements of the particular location where they will be implanted. Although the materials and design features of these valves are continuously being improved, they do increase the risk of clotting in the blood stream, which can lead to a heart attack or stroke. Thus, mechanical valve recipients must take anti-coagulant drugs for life to lessen the potential for blood clot formation. Further, mechanical valves can sometimes suffer from structural problems that may force the patient to have additional surgeries for further valve replacement.
Bioprosthetic valves, which are also referred to as prosthetic valves, generally include both human tissue valves and animal tissue valves. The designs of these bioprosthetic valves are typically relatively similar to the design of the natural valves of the patient and advantageously do not require the use of long-term anti-coagulant drugs. Human tissue valves are typically not available in large quantities, however, since they must be removed from deceased persons who have elected organ donation. On the other hand, due to the large numbers of animals routinely processed at meat processing facilities, for example, animal tissue valves are more widely available for the patients who require valve replacement. The most common types of animal tissue valves used include porcine aortic valves, and bovine and porcine pericardial valves, some of which are incorporated with some type of a stent before implantation in a patient. In the case of pericardial valves, the use of pericardial material to design and make the heart valves provides a much larger range of design options than is available when using only harvested valves.
In order to incorporate a tissue valve with a stent or other type of frame, a number of different techniques and methods have been used, such as clamping, tying, gluing, or stitching, for example. However, many of the techniques used for this purpose generally produce a stented valve that has concentrated stresses at the points where the leaflets are attached to the stent frame. That is, because the stents are relatively rigid as compared to the flexible material from which the leaflets of the tissue valve are made, the repetitive flexing motion of the leaflets can create stress concentrations at the points where the tissue valve is attached to the stent. These stress concentrations can eventually lead to tearing of the tissue, valve leakage, and/or failure of the heart valve. The attachment points can also be sites for abrasion of the tissue that can lead to tearing of the tissue. Thus, there is a continued need to be able to provide methods and devices for a durable attachment between a tissue valve and a stent and/or to distribute the stresses away from the attachment and seam areas and provide for nonabrasive contact surfaces for bioprosthetic heart valve leaflets.
The present invention is directed to a prosthetic cardiac valve and methods of making such a valve. In particular, embodiments of the invention are directed to protection of seams that are formed by the attachment of pieces of tissue material when making a tubular valve.
In one aspect of the invention a multi-leaflet valve is provided, which includes at least two leaflets made from pericardial material, for example, an outer tube, and a seam protector for each seam. Each seam protector is positioned to be in contact with a portion of the outer tube, with tube portions and leaflet ends being positioned between adjacent seam protection pieces. The seam protectors provide a lower stress surface about which the leaflets can bend or flex during their opening and closing. The seam protectors may be configured in a number of different ways, including an enlarged end portion with an extending straight surface, an inverted U-shaped structure, a sinusoidal-shaped structure, and the like. The valve can further be provided with a seam cover or protector that is stitched onto the seam allowance of the layers of one or more of the seams. The seams can be provided with one or more inserts to fill spaces between adjacent tissue layers and create tension in certain material sheets, thereby providing a relatively soft hinging surface for the leaflets.
In one aspect of the invention, seam protection is provided by configuring a free end of tube material into a roll or coil at the seam area. In another aspect of the invention, a strip of material can be provided for seam support and to provide an element about which leaflets can bend.
In another aspect of the invention, a sheet of pericardium material can be cut or otherwise made into a disc of material from which a hole is cut in its central area. The inner hole can be attached to a stent frame and a plate or other fixture can be used to form the leaflet shapes.
The present invention will be further explained with reference to the appended Figures, wherein like structure is referred to by like numerals throughout the several views, and wherein:
a through 21b are schematic top views of seam protectors in pairs, where each pair of Figures includes the seam protector in its operational position and a mold configuration for making that seam protector;
Pericardial valves of the invention can be used for replacement of pulmonary valves, aortic valves, mitral valves, or tricuspid valves, in accordance with the methods and valve constructions of the invention described herein. Alternatively, the valves of the invention can be used to replace a failed bioprosthesis, such as in the area of an aortic valve or mitral valve, for example. The shape, size, and configuration of the outer tubular portion of the pericardial valve can specifically be designed and chosen for the type of valve that is being produced. The valves of the invention can include stented or stentless valves, but in either case, the valves are preferably compressible to a reduced diameter during the implantation process, such as for transcatheter implantation, and can be capable of being expanded to a larger diameter once they are in their desired implantation location. The valve assemblies can be used as a surgical sutureless or apical implant, and can be utilized in percutaneous replacement of cardiac valves, for example. One exemplary method for assembling a stented valve of the invention generally includes the manufacture and preparation of a valve segment, then a subsequent mounting or attachment of the prepared valve segment to a stent, which is described in further detail below.
Referring now to the Figures, wherein the components are labeled with like numerals throughout the several Figures, and initially to
The piece of pericardium can then be cut to a predetermined shape and size to make the valve walls and leaflets of the valve assemblies of the invention, as will be described in detail relative to a number of embodiments of the invention. If the material is thicker than desired, the thickness can be reduced using a number of methods for effectively removing some of the thickness of the pericardium material without sacrificing an undesirable amount of the strength of the material.
Referring to
The seam protector comprises a first side piece 20 positioned to be in contact with the first outer tube portion 16 and a second side piece 22 (which is optionally configured to mirror the first side piece 20) positioned to be in contact with the second outer tube portion 18. The side pieces 20, 22 may be molded out of silicone, reinforced silicone, or plastic, for example, and are at least slightly more rigid than the leaflet and outer tube materials of the valve. As shown, each of the side pieces 20, 22 includes an enlarged end portion 26 from which a straight or flat portion 28 extends. The relative sizes and shapes shown for the enlarged end 26 and straight portions 28 of the side pieces 20, 22 are exemplary and can be different from that shown in the figures. In any case, the enlarged end portion 26 of each of the side pieces 20, 22 can be relatively cylindrical in shape and can provide a relatively gentle transition area for the outer tube portions. In this way, the stress concentrations in this area can be reduced. In addition, the enlarged end portion 26 provides a smooth surface to minimize abrasion where the leaflets open and close. Further, side pieces 28 can include multiple sewing holes 24, as shown in
In order to assemble pericardial pieces at each of the seams of a tri-leaflet valve, three pieces of tissue are provided for the leaflets, each of which will be stitched outside of the stitch line that would normally be used. This stitching will position the seams away from the point or line along which the leaflets open and close. It is also contemplated to tack certain pieces of the pericardium that will be part of the structure to portions of a seam protector prior to placing all of the pieces in contact with each other. It is further contemplated that a clamp can be used to hold the pieces together during and/or after the stitching is complete.
Three similar or identical seam arrangements can be used to form a tubular structure of the type referred to as a tri-leaflet valve, or the seams can be configured differently from each other. In any case, seam protectors are preferably provided at each of the three seam areas. The valve assembly can then be attached to a compressible stent or other compressible structure for percutaneous or surgical delivery to the heart of a patient, for example.
A variety of exemplary shapes for seam covers and molds for making these seam covers are shown in
When stitching any of the seam covers described above to the seam of a valve, it may be desirable to use a template; however, in order to use a template for a seam cover (which may be made of silicone or the like) while also minimizing the bulkiness of the seam, enough surface area should be provided for clamping the materials onto the template. That is, the width of the seam cover can be increased to be at least slightly larger than necessary, and the extra material can be trimmed away after the seam has been stitched.
Additional seam constructions are illustrated in
In the top schematic view of
A variety of sewing strips can be used in combination with other features of the invention relative to seam construction, or the sewing strips that are shown and described herein relative to
In many of the embodiments described herein, the pericardial valve is prepared to include three leaflets, but may optionally have more or less than three leaflets, which can be formed by selecting the desired number of leaflet and outer tube components. The three leaflet embodiment can be used in areas of the heart that typically have a three leaflet valve, such as the pulmonary valve and aortic valve, although the three leaflet embodiment can also be used as a replacement for the two leaflet mitral valve. Alternatively, a two leaflet or single leaflet embodiment of the valve of the invention is contemplated, which can be used in areas of the heart that typically have a three leaflet valve, such as the pulmonary valve, for example. Certain considerations for blood flow will determine particular parameters of the valve used, as will be explained in further detail below.
The valve constructions of the invention may be used alone as a stentless valve, or the valve segments may be attached to a support structure such as a stent. The stent may be compressible for percutaneous delivery to the heart of a patient, for example. The stent used may take the form of a series of zig-zag ring structures and may be fabricated of platinum, stainless steel, or other biocompatible metal or polymer. The stent used may alternatively be fabricated using wire stock or may be produced by machining the stent from a metal tube, as is commonly employed in the manufacturing of stents. The number of wires, the positioning of such wires, and various other features of the stent chosen can vary considerably. Thus, the specifics of the stent can vary widely, such that many other known generally cylindrical stent configurations may be used within the scope of the invention. A series of zig-zag ring structures can be coupled longitudinally to one another to form a generally cylindrical-shaped structure, although it is understood that the structures can be arranged in an at least slightly oval or elliptical shape. Each ring structure can take the form of a series of adjacent generally straight sections, which each meet one another at one end at a curved or angled junction to form a “V” or “U” shaped structure.
Once a valve segment and stent are positioned relative to each other, the stent can be secured to the valve segment in a variety of ways. One procedure that can be used is to suture certain areas of the stent to the valve segment. The suture material may be provided as a monofilament or multifilament structure made of natural or synthetic materials (e.g., nylon or polypropylene), or may alternatively include an elongated metal or metal-composite thread or filament that is suitable for permanently securing the stent to the valve segment in accordance with the present invention. The number and location of suture points can vary, but should include an adequate number of connection points that are positioned in predetermined locations that prevent movement of the stent relative to the valve segment, particularly during the compression of the stent for percutaneous delivery and expansion of the stent for its deployment.
The valves or stented valves of the invention can be subjected to suitable chemical fixation and/or bioburden reduction treatments, which may vary considerably. Chemical fixation helps to preserve the tissue, render it inert, reduce the risk of host rejection, and/or the like. Chemical fixation may occur by submerging the valve in a suitable reagent for a period of about 3 hours under slight pressure and ambient temperature and then for 72 hours under ambient pressure and temperature. By way of example, a 0.2 weight percent gluteraldehyde solution at physiological pH and being phosphate buffered may be used for chemical fixation. The valve may then be stored in a suitable storage reagent (e.g., an aqueous solution containing 0.2% by weight gluteraldehyde) until subsequent use. Bioburden reduction may be carried out by submerging the tissue in a suitable reagent for a period of 48 to 72 hours at ambient temperature. By way of example, an aqueous solution containing 1% by weight gluteraldehyde and 20% by weight isopropyl alcohol at physiological pH and being phosphate-buffered may be used for bioburden reduction. This solution would be suitable for use as a packaging solution as well. A variety of fixation tines, concentrations, pH levels and chemicals can be used in accordance with the invention. After suitable treatments to the valve are complete and after appropriate rinsing of the valve, the device can be used for implantation into a human.
When valves of the invention are made into a stented valve, the stented valves may be used with a system for delivering the valve segment to the desired location within a patient. The delivery system may include, for example, an outer sheath overlying an inner balloon catheter, where the outer sheath includes an expanded distal portion, within which the stented valve is located. The stented valve can be compressed around a single or double balloon located on the inner catheter. A tapered tip mounted to the distal end of the inner catheter can ease the passage of the delivery system through the patient's vasculature. The system also may include some type of guidewire to guide the delivery system to its desired implant location. Another alternative delivery system that can be used, in particular, for stented valves having a self-expanding stent, includes a catheter that does not have balloons, but instead includes a sheath or other mechanism that maintains the self-expanding stent in its compressed condition until it is desired to allow it to expand. When such a self-expanding stent is properly positioned in the patient, the mechanism that keeps the stent compressed can be retracted or otherwise removed to allow for expansion of the stent against the vessel walls.
The delivery system and its use may be used where the stented valve can be expanded against a failed native or prosthetic valve. The delivery system can be advanced to the desired valve implant site using the guidewire, after which the sheath is moved proximally, exposing the valve and balloon mounted on inner catheter. The balloon is expanded, which thereby expands stented valve until it reaches a desired outer diameter where it contacts the wall of a heart vessel. The balloon is then deflated and the delivery system is withdrawn proximally.
The present invention has now been described with reference to several embodiments thereof. The entire disclosure of any patent or patent application identified herein is hereby incorporated by reference. The foregoing detailed description and examples have been given for clarity of understanding only. No unnecessary limitations are to be understood therefrom. It will be apparent to those skilled in the art that many changes can be made in the embodiments described without departing from the scope of the invention. Thus, the scope of the present invention should not be limited to the structures described herein, but only by the structures described by the language of the claims and the equivalents of those structures.
The present application claims priority to U.S. Provisional Application Nos. 61/125,203, filed Apr. 23, 2008, and titled “Tissue Attachment Devices and Methods for Prosthetic Heart Valves” the entire contents of which is incorporated herein by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
3657744 | Ersek | Apr 1972 | A |
3671979 | Moulopoulos | Jun 1972 | A |
3714671 | Edwards et al. | Feb 1973 | A |
3755823 | Hancock | Sep 1973 | A |
3868956 | Alfidi et al. | Mar 1975 | A |
4035849 | Angell et al. | Jul 1977 | A |
4056854 | Boretos et al. | Nov 1977 | A |
4106129 | Carpentier et al. | Aug 1978 | A |
4192020 | Davis et al. | Mar 1980 | A |
4222126 | Boretos et al. | Sep 1980 | A |
4265694 | Boretos | May 1981 | A |
4297749 | Davis et al. | Nov 1981 | A |
4343048 | Ross et al. | Aug 1982 | A |
4345340 | Rosen | Aug 1982 | A |
4388735 | Ionescu et al. | Jun 1983 | A |
4425908 | Simon | Jan 1984 | A |
4441216 | Ionescu et al. | Apr 1984 | A |
4470157 | Love | Sep 1984 | A |
4501030 | Lane | Feb 1985 | A |
4574803 | Storz | Mar 1986 | A |
4580568 | Gianturco | Apr 1986 | A |
4592340 | Boyles | Jun 1986 | A |
4610688 | Silvestrini et al. | Sep 1986 | A |
4647283 | Carpentier et al. | Mar 1987 | A |
4648881 | Carpentier et al. | Mar 1987 | A |
4665906 | Jervis | May 1987 | A |
4681908 | Broderick et al. | Jul 1987 | A |
4710192 | Liotta et al. | Dec 1987 | A |
4787899 | Lazarus | Nov 1988 | A |
4787901 | Baykut | Nov 1988 | A |
4796629 | Grayzel | Jan 1989 | A |
4819751 | Shimada et al. | Apr 1989 | A |
4834755 | Silvestrini et al. | May 1989 | A |
4856516 | Hillstead | Aug 1989 | A |
4872874 | Taheri | Oct 1989 | A |
4878495 | Grayzel | Nov 1989 | A |
4878906 | Lindemann et al. | Nov 1989 | A |
4883458 | Shiber | Nov 1989 | A |
4909252 | Goldberger | Mar 1990 | A |
4917102 | Miller et al. | Apr 1990 | A |
4922905 | Strecker | May 1990 | A |
4994077 | Dobben | Feb 1991 | A |
5002559 | Tower | Mar 1991 | A |
5026366 | Leckrone | Jun 1991 | A |
5032128 | Alonso | Jul 1991 | A |
5037434 | Lane | Aug 1991 | A |
5047041 | Samuels | Sep 1991 | A |
5059177 | Towne et al. | Oct 1991 | A |
5085635 | Cragg | Feb 1992 | A |
5089015 | Ross | Feb 1992 | A |
5152771 | Sabbaghian et al. | Oct 1992 | A |
5161547 | Tower | Nov 1992 | A |
5163953 | Vince | Nov 1992 | A |
5167628 | Boyles | Dec 1992 | A |
5217483 | Tower | Jun 1993 | A |
5232445 | Bonzel | Aug 1993 | A |
5272909 | Nguyen et al. | Dec 1993 | A |
5295958 | Shturman | Mar 1994 | A |
5327774 | Nguyen et al. | Jul 1994 | A |
5332402 | Teitelbaum | Jul 1994 | A |
5350398 | Pavcnik et al. | Sep 1994 | A |
5370685 | Stevens | Dec 1994 | A |
5389106 | Tower | Feb 1995 | A |
5397351 | Pavcnik et al. | Mar 1995 | A |
5411552 | Andersen et al. | May 1995 | A |
5415633 | Lazarus et al. | May 1995 | A |
5431676 | Dubrul et al. | Jul 1995 | A |
5443446 | Shturman | Aug 1995 | A |
5480424 | Cox | Jan 1996 | A |
5489294 | McVenes et al. | Feb 1996 | A |
5489297 | Duran | Feb 1996 | A |
5496346 | Horzewski et al. | Mar 1996 | A |
5500014 | Quijano et al. | Mar 1996 | A |
5507767 | Maeda et al. | Apr 1996 | A |
5545209 | Roberts et al. | Aug 1996 | A |
5545211 | An et al. | Aug 1996 | A |
5545214 | Stevens | Aug 1996 | A |
5554185 | Block et al. | Sep 1996 | A |
5575818 | Pinchuk | Nov 1996 | A |
5580922 | Park et al. | Dec 1996 | A |
5591195 | Taheri et al. | Jan 1997 | A |
5609626 | Quijano et al. | Mar 1997 | A |
5645559 | Hachtman et al. | Jul 1997 | A |
5667523 | Bynon et al. | Sep 1997 | A |
5674277 | Freitag | Oct 1997 | A |
5702368 | Stevens et al. | Dec 1997 | A |
5713953 | Vallana et al. | Feb 1998 | A |
5716417 | Girard et al. | Feb 1998 | A |
5746709 | Rom et al. | May 1998 | A |
5749890 | Shaknovich | May 1998 | A |
5766151 | Valley et al. | Jun 1998 | A |
5782809 | Umeno et al. | Jul 1998 | A |
5800456 | Maeda et al. | Sep 1998 | A |
5800508 | Goicoechea et al. | Sep 1998 | A |
5817126 | Imran | Oct 1998 | A |
5824041 | Lenker | Oct 1998 | A |
5824043 | Cottone, Jr. | Oct 1998 | A |
5824053 | Khosravi et al. | Oct 1998 | A |
5824056 | Rosenberg | Oct 1998 | A |
5824061 | Quijano et al. | Oct 1998 | A |
5824064 | Taheri | Oct 1998 | A |
5855597 | Jayaraman | Jan 1999 | A |
5855601 | Bessler et al. | Jan 1999 | A |
5860966 | Tower | Jan 1999 | A |
5861028 | Angell | Jan 1999 | A |
5868783 | Tower | Feb 1999 | A |
5891191 | Stinson | Apr 1999 | A |
5895419 | Tweden et al. | Apr 1999 | A |
5906619 | Olson et al. | May 1999 | A |
5913842 | Boyd et al. | Jun 1999 | A |
5925063 | Khosravi | Jul 1999 | A |
5957949 | Leonhardt et al. | Sep 1999 | A |
5968068 | Dehdashtian et al. | Oct 1999 | A |
5984957 | Laptewicz, Jr. et al. | Nov 1999 | A |
5997573 | Quijano et al. | Dec 1999 | A |
6022370 | Tower | Feb 2000 | A |
6027525 | Suh et al. | Feb 2000 | A |
6029671 | Stevens et al. | Feb 2000 | A |
6042589 | Marianne | Mar 2000 | A |
6042598 | Tsugita et al. | Mar 2000 | A |
6042607 | Williamson, IV | Mar 2000 | A |
6051014 | Jang | Apr 2000 | A |
6059809 | Amor et al. | May 2000 | A |
6110201 | Quijano et al. | Aug 2000 | A |
6146366 | Schachar | Nov 2000 | A |
6159239 | Greenhalgh | Dec 2000 | A |
6162245 | Jayaraman | Dec 2000 | A |
6171335 | Wheatley et al. | Jan 2001 | B1 |
6200336 | Pavcnik et al. | Mar 2001 | B1 |
6203550 | Olson | Mar 2001 | B1 |
6210408 | Chandrasekaran et al. | Apr 2001 | B1 |
6218662 | Tchakarov et al. | Apr 2001 | B1 |
6221006 | Dubrul et al. | Apr 2001 | B1 |
6221091 | Khosravi | Apr 2001 | B1 |
6245102 | Jayaraman | Jun 2001 | B1 |
6248116 | Chevilon | Jun 2001 | B1 |
6258114 | Konya et al. | Jul 2001 | B1 |
6258115 | Dubrul | Jul 2001 | B1 |
6258120 | McKenzie et al. | Jul 2001 | B1 |
6277555 | Duran et al. | Aug 2001 | B1 |
6299637 | Shaolia et al. | Oct 2001 | B1 |
6302906 | Goicoechea et al. | Oct 2001 | B1 |
6309382 | Garrison et al. | Oct 2001 | B1 |
6309417 | Spence et al. | Oct 2001 | B1 |
6338735 | Stevens | Jan 2002 | B1 |
6348063 | Yassour et al. | Feb 2002 | B1 |
6350277 | Kocur | Feb 2002 | B1 |
6352708 | Duran et al. | Mar 2002 | B1 |
6371970 | Khosravi et al. | Apr 2002 | B1 |
6371983 | Lane | Apr 2002 | B1 |
6380457 | Yurek et al. | Apr 2002 | B1 |
6398807 | Chouinard et al. | Jun 2002 | B1 |
6409750 | Hyodoh et al. | Jun 2002 | B1 |
6425916 | Garrison et al. | Jul 2002 | B1 |
6440164 | DiMatteo et al. | Aug 2002 | B1 |
6454799 | Schreck | Sep 2002 | B1 |
6458153 | Bailey et al. | Oct 2002 | B1 |
6461382 | Cao | Oct 2002 | B1 |
6475239 | Campbell et al. | Nov 2002 | B1 |
6482228 | Norred | Nov 2002 | B1 |
6488704 | Connelly et al. | Dec 2002 | B1 |
6494909 | Greenhalgh | Dec 2002 | B2 |
6503272 | Duerig et al. | Jan 2003 | B2 |
6508833 | Pavcnik et al. | Jan 2003 | B2 |
6527800 | McGuckin, Jr. et al. | Mar 2003 | B1 |
6530949 | Konya et al. | Mar 2003 | B2 |
6530952 | Vesely | Mar 2003 | B2 |
6562031 | Chandrasekaran et al. | May 2003 | B2 |
6562058 | Seguin et al. | May 2003 | B2 |
6569196 | Vesely | May 2003 | B1 |
6585758 | Chouinard et al. | Jul 2003 | B1 |
6592546 | Barbut et al. | Jul 2003 | B1 |
6605112 | Moll et al. | Aug 2003 | B1 |
6613077 | Gilligan et al. | Sep 2003 | B2 |
6622604 | Chouinard et al. | Sep 2003 | B1 |
6635068 | Dubrul et al. | Oct 2003 | B1 |
6652571 | White et al. | Nov 2003 | B1 |
6652578 | Bailey et al. | Nov 2003 | B2 |
6656213 | Solem | Dec 2003 | B2 |
6673109 | Cox | Jan 2004 | B2 |
6676698 | McGuckin, Jr. et al. | Jan 2004 | B2 |
6682558 | Tu et al. | Jan 2004 | B2 |
6682559 | Myers et al. | Jan 2004 | B2 |
6685739 | DiMatteo et al. | Feb 2004 | B2 |
6689144 | Gerberding | Feb 2004 | B2 |
6689164 | Seguin | Feb 2004 | B1 |
6692512 | Jang | Feb 2004 | B2 |
6692513 | Streeter et al. | Feb 2004 | B2 |
6695878 | McGuckin, Jr. et al. | Feb 2004 | B2 |
6702851 | Chinn et al. | Mar 2004 | B1 |
6719789 | Cox | Apr 2004 | B2 |
6730118 | Spenser et al. | May 2004 | B2 |
6730377 | Wang | May 2004 | B2 |
6733525 | Yang et al. | May 2004 | B2 |
6736846 | Cox | May 2004 | B2 |
6752828 | Thornton | Jun 2004 | B2 |
6769434 | Liddicoat et al. | Aug 2004 | B2 |
6786925 | Schoon | Sep 2004 | B1 |
6790229 | Berreklouw | Sep 2004 | B1 |
6792979 | Konya et al. | Sep 2004 | B2 |
6797002 | Spence | Sep 2004 | B2 |
6821297 | Snyders | Nov 2004 | B2 |
6830575 | Stenzel et al. | Dec 2004 | B2 |
6830584 | Seguin | Dec 2004 | B1 |
6830585 | Artof | Dec 2004 | B1 |
6846325 | Liddicoat | Jan 2005 | B2 |
6866650 | Stevens | Mar 2005 | B2 |
6872223 | Roberts | Mar 2005 | B2 |
6875231 | Anduiza et al. | Apr 2005 | B2 |
6883522 | Spence et al. | Apr 2005 | B2 |
6887266 | Williams et al. | May 2005 | B2 |
6890330 | Streeter et al. | May 2005 | B2 |
6893460 | Spenser et al. | May 2005 | B2 |
6896690 | Lambrecht et al. | May 2005 | B1 |
6908481 | Cribier | Jun 2005 | B2 |
6913600 | Valley et al. | Jul 2005 | B2 |
6929653 | Streeter | Aug 2005 | B2 |
6939365 | Fogarty et al. | Sep 2005 | B1 |
6951571 | Srivastava | Oct 2005 | B1 |
6986742 | Hart et al. | Jan 2006 | B2 |
6989027 | Allen et al. | Jan 2006 | B2 |
6989028 | Lashinski et al. | Jan 2006 | B2 |
6991649 | Sievers | Jan 2006 | B2 |
7018401 | Hyodoh et al. | Mar 2006 | B1 |
7041128 | McGuckin, Jr. et al. | May 2006 | B2 |
7044966 | Svanidze et al. | May 2006 | B2 |
7048014 | Hyodoh et al. | May 2006 | B2 |
7097659 | Woolfson et al. | Aug 2006 | B2 |
7101396 | Artof et al. | Sep 2006 | B2 |
7105016 | Shui et al. | Sep 2006 | B2 |
7115141 | Menz et al. | Oct 2006 | B2 |
7147663 | Berg et al. | Dec 2006 | B1 |
7153324 | Case et al. | Dec 2006 | B2 |
7160319 | Chouinard et al. | Jan 2007 | B2 |
7175656 | Khairkhahan | Feb 2007 | B2 |
7186265 | Sharkawy et al. | Mar 2007 | B2 |
7195641 | Palmaz et al. | Mar 2007 | B2 |
7198646 | Figulla et al. | Apr 2007 | B2 |
7201761 | Woolfson et al. | Apr 2007 | B2 |
7201772 | Schwammenthal et al. | Apr 2007 | B2 |
7252682 | Seguin | Aug 2007 | B2 |
7300457 | Palmaz | Nov 2007 | B2 |
7300463 | Liddicoat | Nov 2007 | B2 |
7316706 | Bloom et al. | Jan 2008 | B2 |
7329278 | Seguin | Feb 2008 | B2 |
7335218 | Wilson et al. | Feb 2008 | B2 |
7338520 | Bailey et al. | Mar 2008 | B2 |
7374571 | Pease et al. | May 2008 | B2 |
7381218 | Schreck | Jun 2008 | B2 |
7384411 | Condado | Jun 2008 | B1 |
7429269 | Schwammenthal et al. | Sep 2008 | B2 |
7442204 | Schwammenthal et al. | Oct 2008 | B2 |
7462191 | Spenser et al. | Dec 2008 | B2 |
7470284 | Lambrecht et al. | Dec 2008 | B2 |
7473275 | Marquez | Jan 2009 | B2 |
7481838 | Carpentier et al. | Jan 2009 | B2 |
7544206 | Cohn et al. | Jun 2009 | B2 |
7556646 | Yang et al. | Jul 2009 | B2 |
7628805 | Spenser et al. | Dec 2009 | B2 |
7758640 | Vesely | Jul 2010 | B2 |
8052750 | Tuval et al. | Nov 2011 | B2 |
8500798 | Rowe et al. | Aug 2013 | B2 |
8568475 | Nguyen et al. | Oct 2013 | B2 |
20010001314 | Davison et al. | May 2001 | A1 |
20010002445 | Vesely | May 2001 | A1 |
20010007956 | Letac et al. | Jul 2001 | A1 |
20010010017 | Letac et al. | Jul 2001 | A1 |
20010011189 | Drasler et al. | Aug 2001 | A1 |
20010021872 | Bailey et al. | Sep 2001 | A1 |
20010025196 | Chinn et al. | Sep 2001 | A1 |
20010032013 | Marton | Oct 2001 | A1 |
20010039450 | Pavcnik et al. | Nov 2001 | A1 |
20010041928 | Pavcnik et al. | Nov 2001 | A1 |
20010044647 | Pinchuk et al. | Nov 2001 | A1 |
20020010508 | Chobotov | Jan 2002 | A1 |
20020029014 | Jayaraman | Mar 2002 | A1 |
20020032480 | Spence et al. | Mar 2002 | A1 |
20020032481 | Gabbay | Mar 2002 | A1 |
20020035396 | Heath | Mar 2002 | A1 |
20020042650 | Vardi et al. | Apr 2002 | A1 |
20020052651 | Myers et al. | May 2002 | A1 |
20020058995 | Stevens | May 2002 | A1 |
20020072789 | Hackett et al. | Jun 2002 | A1 |
20020099439 | Schwartz et al. | Jul 2002 | A1 |
20020103533 | Langberg et al. | Aug 2002 | A1 |
20020107565 | Greenhalgh | Aug 2002 | A1 |
20020111674 | Chouinard et al. | Aug 2002 | A1 |
20020123802 | Snyders | Sep 2002 | A1 |
20020133183 | Lentz et al. | Sep 2002 | A1 |
20020133226 | Marquez et al. | Sep 2002 | A1 |
20020138138 | Yang | Sep 2002 | A1 |
20020151970 | Garrison et al. | Oct 2002 | A1 |
20020161392 | Dubrul | Oct 2002 | A1 |
20020161394 | Macoviak et al. | Oct 2002 | A1 |
20020193871 | Beyersdorf et al. | Dec 2002 | A1 |
20030014104 | Cribier | Jan 2003 | A1 |
20030023300 | Bailey et al. | Jan 2003 | A1 |
20030023303 | Palmaz et al. | Jan 2003 | A1 |
20030028247 | Cali | Feb 2003 | A1 |
20030036791 | Philipp et al. | Feb 2003 | A1 |
20030040772 | Hyodoh et al. | Feb 2003 | A1 |
20030040792 | Gabbay | Feb 2003 | A1 |
20030050694 | Yang et al. | Mar 2003 | A1 |
20030055495 | Pease et al. | Mar 2003 | A1 |
20030065386 | Weadock | Apr 2003 | A1 |
20030109924 | Cribier | Jun 2003 | A1 |
20030125795 | Pavcnik et al. | Jul 2003 | A1 |
20030130726 | Thorpe et al. | Jul 2003 | A1 |
20030130729 | Paniagua et al. | Jul 2003 | A1 |
20030139804 | Hankh et al. | Jul 2003 | A1 |
20030149475 | Hyodoh et al. | Aug 2003 | A1 |
20030149476 | Damm et al. | Aug 2003 | A1 |
20030149478 | Figulla et al. | Aug 2003 | A1 |
20030153974 | Spenser et al. | Aug 2003 | A1 |
20030181850 | Diamond et al. | Sep 2003 | A1 |
20030191519 | Lombardi et al. | Oct 2003 | A1 |
20030199913 | Dubrul et al. | Oct 2003 | A1 |
20030199963 | Tower et al. | Oct 2003 | A1 |
20030199971 | Tower et al. | Oct 2003 | A1 |
20030212410 | Stenzel et al. | Nov 2003 | A1 |
20030212454 | Scott et al. | Nov 2003 | A1 |
20040034411 | Quijano et al. | Feb 2004 | A1 |
20040039436 | Spenser et al. | Feb 2004 | A1 |
20040049224 | Buehlmann et al. | Mar 2004 | A1 |
20040049262 | Obermiller et al. | Mar 2004 | A1 |
20040049266 | Anduiza et al. | Mar 2004 | A1 |
20040082904 | Houde et al. | Apr 2004 | A1 |
20040088045 | Cox | May 2004 | A1 |
20040093005 | Durcan | May 2004 | A1 |
20040093060 | Sequin et al. | May 2004 | A1 |
20040097788 | Mourles et al. | May 2004 | A1 |
20040098112 | DiMatteo et al. | May 2004 | A1 |
20040106976 | Bailey et al. | Jun 2004 | A1 |
20040106990 | Spence et al. | Jun 2004 | A1 |
20040111096 | Tu et al. | Jun 2004 | A1 |
20040116951 | Rosengart | Jun 2004 | A1 |
20040117004 | Osborne et al. | Jun 2004 | A1 |
20040122468 | Yodfat et al. | Jun 2004 | A1 |
20040122516 | Fogarty | Jun 2004 | A1 |
20040127979 | Wilson | Jul 2004 | A1 |
20040138742 | Myers et al. | Jul 2004 | A1 |
20040138743 | Myers et al. | Jul 2004 | A1 |
20040153146 | Lashinski et al. | Aug 2004 | A1 |
20040167573 | Williamson | Aug 2004 | A1 |
20040167620 | Ortiz | Aug 2004 | A1 |
20040186563 | Iobbi | Sep 2004 | A1 |
20040193261 | Berreklouw | Sep 2004 | A1 |
20040210240 | Saint | Oct 2004 | A1 |
20040210304 | Seguin et al. | Oct 2004 | A1 |
20040210307 | Khairkhahan | Oct 2004 | A1 |
20040215333 | Duran | Oct 2004 | A1 |
20040215339 | Drasler et al. | Oct 2004 | A1 |
20040225353 | McGuckin, Jr. | Nov 2004 | A1 |
20040225354 | Allen et al. | Nov 2004 | A1 |
20040254636 | Flagle et al. | Dec 2004 | A1 |
20040260394 | Douk et al. | Dec 2004 | A1 |
20040267357 | Allen et al. | Dec 2004 | A1 |
20050010246 | Streeter | Jan 2005 | A1 |
20050010285 | Lambrecht et al. | Jan 2005 | A1 |
20050010287 | Macoviak | Jan 2005 | A1 |
20050015112 | Cohn et al. | Jan 2005 | A1 |
20050027348 | Case et al. | Feb 2005 | A1 |
20050033398 | Seguin | Feb 2005 | A1 |
20050043790 | Seguin | Feb 2005 | A1 |
20050049692 | Numamoto | Mar 2005 | A1 |
20050049696 | Siess | Mar 2005 | A1 |
20050055088 | Liddicoat et al. | Mar 2005 | A1 |
20050060029 | Le | Mar 2005 | A1 |
20050060030 | Lashinski et al. | Mar 2005 | A1 |
20050075584 | Cali | Apr 2005 | A1 |
20050075712 | Biancucci | Apr 2005 | A1 |
20050075717 | Nguyen | Apr 2005 | A1 |
20050075719 | Bergheim | Apr 2005 | A1 |
20050075724 | Svanidze | Apr 2005 | A1 |
20050075727 | Wheatley | Apr 2005 | A1 |
20050075730 | Myers | Apr 2005 | A1 |
20050075731 | Artof | Apr 2005 | A1 |
20050085841 | Eversull et al. | Apr 2005 | A1 |
20050085842 | Eversull et al. | Apr 2005 | A1 |
20050085843 | Opolski et al. | Apr 2005 | A1 |
20050085890 | Rasmussen et al. | Apr 2005 | A1 |
20050085900 | Case et al. | Apr 2005 | A1 |
20050096568 | Kato | May 2005 | A1 |
20050096692 | Linder et al. | May 2005 | A1 |
20050096724 | Stenzel et al. | May 2005 | A1 |
20050096734 | Majercak et al. | May 2005 | A1 |
20050096735 | Hojeibane et al. | May 2005 | A1 |
20050096736 | Osse et al. | May 2005 | A1 |
20050096738 | Cali et al. | May 2005 | A1 |
20050096739 | Cao | May 2005 | A1 |
20050107871 | Realyvasquez et al. | May 2005 | A1 |
20050113910 | Paniagua | May 2005 | A1 |
20050119688 | Bergheim | Jun 2005 | A1 |
20050131438 | Cohn | Jun 2005 | A1 |
20050137686 | Salahieh | Jun 2005 | A1 |
20050137688 | Salahieh et al. | Jun 2005 | A1 |
20050137692 | Haug | Jun 2005 | A1 |
20050137695 | Salahieh | Jun 2005 | A1 |
20050137701 | Salahieh | Jun 2005 | A1 |
20050143809 | Salahieh | Jun 2005 | A1 |
20050148997 | Valley et al. | Jul 2005 | A1 |
20050149181 | Eberhardt | Jul 2005 | A1 |
20050165477 | Anduiza et al. | Jul 2005 | A1 |
20050187616 | Realyvasquez | Aug 2005 | A1 |
20050203549 | Realyvasquez | Sep 2005 | A1 |
20050203605 | Dolan | Sep 2005 | A1 |
20050203618 | Sharkawy | Sep 2005 | A1 |
20050222674 | Paine | Oct 2005 | A1 |
20050228495 | Macoviak | Oct 2005 | A1 |
20050234546 | Nugent | Oct 2005 | A1 |
20050240200 | Bergheim | Oct 2005 | A1 |
20050240263 | Fogarty et al. | Oct 2005 | A1 |
20050261759 | Lambrecht et al. | Nov 2005 | A1 |
20050283962 | Boudjemline | Dec 2005 | A1 |
20060004439 | Spenser et al. | Jan 2006 | A1 |
20060009841 | McGuckin et al. | Jan 2006 | A1 |
20060052867 | Revuelta et al. | Mar 2006 | A1 |
20060058775 | Stevens et al. | Mar 2006 | A1 |
20060089711 | Dolan | Apr 2006 | A1 |
20060100685 | Seguin et al. | May 2006 | A1 |
20060116757 | Lashinski et al. | Jun 2006 | A1 |
20060135964 | Vesely | Jun 2006 | A1 |
20060142848 | Gabbay | Jun 2006 | A1 |
20060167474 | Bloom et al. | Jul 2006 | A1 |
20060178740 | Stacchino et al. | Aug 2006 | A1 |
20060195134 | Crittenden | Aug 2006 | A1 |
20060206192 | Tower et al. | Sep 2006 | A1 |
20060206202 | Bonhoefer et al. | Sep 2006 | A1 |
20060217802 | Ruiz et al. | Sep 2006 | A1 |
20060229719 | Marquez et al. | Oct 2006 | A1 |
20060247763 | Slater | Nov 2006 | A1 |
20060259134 | Schwammenthal et al. | Nov 2006 | A1 |
20060259136 | Nguyen et al. | Nov 2006 | A1 |
20060259137 | Artof et al. | Nov 2006 | A1 |
20060265056 | Nguyen et al. | Nov 2006 | A1 |
20060271166 | Thill et al. | Nov 2006 | A1 |
20060271175 | Woolfson et al. | Nov 2006 | A1 |
20060276874 | Wilson et al. | Dec 2006 | A1 |
20060282161 | Huynh et al. | Dec 2006 | A1 |
20070005129 | Damm et al. | Jan 2007 | A1 |
20070005131 | Taylor | Jan 2007 | A1 |
20070010878 | Rafiee et al. | Jan 2007 | A1 |
20070016286 | Herrmann et al. | Jan 2007 | A1 |
20070016288 | Gurskis et al. | Jan 2007 | A1 |
20070027518 | Case et al. | Feb 2007 | A1 |
20070027533 | Douk | Feb 2007 | A1 |
20070043435 | Seguin et al. | Feb 2007 | A1 |
20070051377 | Douk et al. | Mar 2007 | A1 |
20070073392 | Heyninck-Jantz | Mar 2007 | A1 |
20070078509 | Lotfy et al. | Apr 2007 | A1 |
20070078510 | Ryan | Apr 2007 | A1 |
20070088431 | Bourang et al. | Apr 2007 | A1 |
20070093869 | Bloom et al. | Apr 2007 | A1 |
20070100439 | Cangialosi | May 2007 | A1 |
20070100440 | Figulla | May 2007 | A1 |
20070100449 | O'Neil et al. | May 2007 | A1 |
20070112415 | Bartlett | May 2007 | A1 |
20070162102 | Ryan et al. | Jul 2007 | A1 |
20070162113 | Sharkawy et al. | Jul 2007 | A1 |
20070185513 | Woolfson et al. | Aug 2007 | A1 |
20070203391 | Bloom et al. | Aug 2007 | A1 |
20070208550 | Cao et al. | Sep 2007 | A1 |
20070225681 | House | Sep 2007 | A1 |
20070232898 | Huynh et al. | Oct 2007 | A1 |
20070233228 | Eberhardt et al. | Oct 2007 | A1 |
20070233237 | Krivoruchko | Oct 2007 | A1 |
20070233238 | Huynh et al. | Oct 2007 | A1 |
20070238979 | Huynh et al. | Oct 2007 | A1 |
20070239254 | Marchand et al. | Oct 2007 | A1 |
20070239265 | Birdsall | Oct 2007 | A1 |
20070239266 | Birdsall | Oct 2007 | A1 |
20070239269 | Dolan et al. | Oct 2007 | A1 |
20070239273 | Allen | Oct 2007 | A1 |
20070244544 | Birdsall et al. | Oct 2007 | A1 |
20070244545 | Birdsall et al. | Oct 2007 | A1 |
20070244546 | Francis | Oct 2007 | A1 |
20070244553 | Rafiee et al. | Oct 2007 | A1 |
20070244554 | Rafiee et al. | Oct 2007 | A1 |
20070244555 | Rafiee et al. | Oct 2007 | A1 |
20070244556 | Rafiee et al. | Oct 2007 | A1 |
20070244557 | Rafiee et al. | Oct 2007 | A1 |
20070250160 | Rafiee | Oct 2007 | A1 |
20070255394 | Ryan | Nov 2007 | A1 |
20070255396 | Douk et al. | Nov 2007 | A1 |
20070288000 | Bonan | Dec 2007 | A1 |
20080004688 | Spenser et al. | Jan 2008 | A1 |
20080004696 | Vesely | Jan 2008 | A1 |
20080009940 | Cribier | Jan 2008 | A1 |
20080015671 | Bonhoeffer | Jan 2008 | A1 |
20080021552 | Gabbay | Jan 2008 | A1 |
20080048656 | Tan | Feb 2008 | A1 |
20080065011 | Marchand et al. | Mar 2008 | A1 |
20080065206 | Liddicoat | Mar 2008 | A1 |
20080071361 | Tuval et al. | Mar 2008 | A1 |
20080071362 | Tuval et al. | Mar 2008 | A1 |
20080071363 | Tuval et al. | Mar 2008 | A1 |
20080071366 | Tuval et al. | Mar 2008 | A1 |
20080071368 | Tuval et al. | Mar 2008 | A1 |
20080077234 | Styrc | Mar 2008 | A1 |
20080082165 | Wilson et al. | Apr 2008 | A1 |
20080082166 | Styrc et al. | Apr 2008 | A1 |
20080133003 | Seguin et al. | Jun 2008 | A1 |
20080140189 | Nguyen et al. | Jun 2008 | A1 |
20080147105 | Wilson et al. | Jun 2008 | A1 |
20080147180 | Ghione et al. | Jun 2008 | A1 |
20080147181 | Ghione et al. | Jun 2008 | A1 |
20080147182 | Righini et al. | Jun 2008 | A1 |
20080154356 | Obermiller et al. | Jun 2008 | A1 |
20080161910 | Revuelta et al. | Jul 2008 | A1 |
20080161911 | Revuelta et al. | Jul 2008 | A1 |
20080183273 | Mesana et al. | Jul 2008 | A1 |
20080188928 | Salahieh et al. | Aug 2008 | A1 |
20080215143 | Seguin et al. | Sep 2008 | A1 |
20080215144 | Ryan et al. | Sep 2008 | A1 |
20080228254 | Ryan | Sep 2008 | A1 |
20080228263 | Ryan | Sep 2008 | A1 |
20080234797 | Styrc | Sep 2008 | A1 |
20080243246 | Ryan et al. | Oct 2008 | A1 |
20080255651 | Dwork | Oct 2008 | A1 |
20080255660 | Guyenot et al. | Oct 2008 | A1 |
20080255661 | Straubinger et al. | Oct 2008 | A1 |
20080262593 | Ryan et al. | Oct 2008 | A1 |
20090005863 | Goetz et al. | Jan 2009 | A1 |
20090012600 | Styrc et al. | Jan 2009 | A1 |
20090048656 | Wen | Feb 2009 | A1 |
20090054976 | Tuval et al. | Feb 2009 | A1 |
20090069886 | Suri et al. | Mar 2009 | A1 |
20090069887 | Righini et al. | Mar 2009 | A1 |
20090069889 | Suri et al. | Mar 2009 | A1 |
20090138079 | Tuval et al. | May 2009 | A1 |
20090164004 | Cohn | Jun 2009 | A1 |
20090171447 | VonSegesser et al. | Jul 2009 | A1 |
20090192585 | Bloom et al. | Jul 2009 | A1 |
20090192586 | Tabor et al. | Jul 2009 | A1 |
20090192591 | Ryan et al. | Jul 2009 | A1 |
20090198316 | Laske et al. | Aug 2009 | A1 |
20090216310 | Straubinger et al. | Aug 2009 | A1 |
20090216312 | Straubinger et al. | Aug 2009 | A1 |
20090216313 | Straubinger et al. | Aug 2009 | A1 |
20090240264 | Tuval et al. | Sep 2009 | A1 |
20090240320 | Tuval | Sep 2009 | A1 |
20090287299 | Tabor et al. | Nov 2009 | A1 |
20090292350 | Eberhardt et al. | Nov 2009 | A1 |
20100011564 | Millwee et al. | Jan 2010 | A1 |
20100018447 | Holecek et al. | Jan 2010 | A1 |
20100023120 | Holecek et al. | Jan 2010 | A1 |
20100036484 | Hariton et al. | Feb 2010 | A1 |
20100094411 | Tuval et al. | Apr 2010 | A1 |
20100100167 | Bortlein et al. | Apr 2010 | A1 |
20100131054 | Tuval et al. | May 2010 | A1 |
20100137979 | Tuval et al. | Jun 2010 | A1 |
20110276128 | Cao et al. | Nov 2011 | A1 |
20120203335 | Vesely et al. | Aug 2012 | A1 |
Number | Date | Country |
---|---|---|
2007-100074433 | Aug 2007 | CN |
195 32 846 | Mar 1997 | DE |
195 46 692 | Jun 1997 | DE |
195 46 692 | Jun 1997 | DE |
198 57 887 | Jul 2000 | DE |
199 07 646 | Aug 2000 | DE |
100 48 814 | Sep 2000 | DE |
10 49 815 | Apr 2002 | DE |
100 49 812 | Apr 2002 | DE |
100 49 813 | Apr 2002 | DE |
0103546 | Mar 1984 | EP |
0597967 | Dec 1994 | EP |
0850607 | Jul 1998 | EP |
1057459 | Jun 2000 | EP |
1057460 | Jun 2000 | EP |
1088529 | Apr 2001 | EP |
1255510 | Nov 2002 | EP |
0937439 | Sep 2003 | EP |
1340473 | Sep 2003 | EP |
0819013 | Jun 2004 | EP |
2788217 | Dec 1999 | FR |
2056023 | Mar 1981 | GB |
2433700 | Dec 2007 | GB |
9529640 | Nov 1995 | WO |
9814137 | Apr 1998 | WO |
9829057 | Jul 1998 | WO |
9933414 | Jul 1999 | WO |
0041652 | Jul 2000 | WO |
0044313 | Aug 2000 | WO |
0047136 | Aug 2000 | WO |
0047139 | Aug 2000 | WO |
0135870 | May 2001 | WO |
0149213 | Jul 2001 | WO |
0154625 | Aug 2001 | WO |
0162189 | Aug 2001 | WO |
0164137 | Sep 2001 | WO |
0176510 | Oct 2001 | WO |
0222054 | Mar 2002 | WO |
0236048 | May 2002 | WO |
0241789 | May 2002 | WO |
0243620 | Jun 2002 | WO |
0247575 | Jun 2002 | WO |
0249540 | Jun 2002 | WO |
03003943 | Jan 2003 | WO |
03003949 | Jan 2003 | WO |
03011195 | Feb 2003 | WO |
03030776 | Apr 2003 | WO |
2004019811 | Mar 2004 | WO |
2004019825 | Mar 2004 | WO |
2004023980 | Mar 2004 | WO |
2004041126 | May 2004 | WO |
2004058106 | Jul 2004 | WO |
2004089250 | Oct 2004 | WO |
2005004753 | Jan 2005 | WO |
2005027790 | Mar 2005 | WO |
2005046528 | May 2005 | WO |
2008047354 | Apr 2008 | WO |
2008079962 | Jul 2008 | WO |
2008100599 | Aug 2008 | WO |
2008150529 | Dec 2008 | WO |
2009002548 | Dec 2008 | WO |
2009029199 | Mar 2009 | WO |
2009042196 | Apr 2009 | WO |
2009045338 | Apr 2009 | WO |
2009061389 | May 2009 | WO |
2009091509 | Jul 2009 | WO |
Entry |
---|
U.S. Appl. No. 12/476,702, filed Jun. 2, 2009. |
U.S. Appl. No. 12/711,289, filed Feb. 24, 2010. |
Andersen, H.R. et al, “Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs.” Euro. Heart J. (1992) 13:704-708. |
Babaliaros, et al., “State of the Art Percutaneous Intervention for the Treatment of Valvular Heart Disease: A Review of the Current Technologies and Ongoing Research in the Field of Percutaneous Heart Valve Replacement and Repair,” Cardiology 2007; 107:87-96. |
Bailey, “Percutaneous Expandable Prosthetic Valves,” In: Topol EJ, ed. Textbook of Interventional Cardiology. vol. II. Second edition. WB Saunders, Philadelphia, 1994:1268-1276. |
Block, et al., “Percutaneous Approaches to Valvular Heart Disease,” Current Cardiology Reports, vol. 7 (2005) pp. 108-113. |
Bonhoeffer, et al, “Percutaneous Replacement of Pulmonary Valve in a Right-Ventricle to Pulmonary-Artery Prosthetic Conduit with Valve Dysfunction,” Lancet (England), Oct. 21, 2000, pp. 1403-1405. |
Bonhoeffer, et al, “Transcatheter Implantation of a Bovine Valve in Pulmonary Position: A Lamb Study,” Circulation (United States), Aug. 15, 2000, pp. 813-816. |
Boudjemline, et al, “Images in Cardiovascular Medicine. Percutaneous Aortic Valve Replacement in Animals,” Circulation (United States), Mar. 16, 2004, 109, p. e161. |
Boudjemline, et al, “Percutaneous Aortic Valve Replacement: Will We Get There?” Heart (British Cardiac Society) (England), Dec. 2001, pp. 705-706. |
Boudjemline, et al, “Percutaneous Implantation of a Biological Valve in the Aorta to Treat Aortic Valve Insufficiency—A Sheep Study,” Medical Science Monitor—International Medical Journal of Experimental and Clinical Research (Poland), Apr. 2002, pp. BR113-BR116. |
Boudjemline, et al, “Percutaneous Implantation of a Biological Valve in Aortic Position: Preliminary Results in a Sheep Study,” European Heart Journal 22, Sep. 2001, p. 630. |
Boudjemline, et al, “Percutaneous Pulmonary Valve Replacement in a Large Right Ventricular Outflow Tract: An Experimental Study,” Journal of the American College of Cardiology (United States), Mar. 17, 2004, pp. 1082-1087. |
Boudjemline, et al, “Percutaneous Valve Insertion: A New Approach,” Journal of Thoracic and Cardiovascular Surgery (United States), Mar. 2003, pp. 741-742. |
Boudjemline, et al, “Steps Toward Percutaneous Aortic Valve Replacement,” Circulation (United States), Feb. 12, 2002, pp. 775-758. |
Boudjemline, et al, “The Percutaneous Implantable Heart Valve,” Progress in Pediatric Cardiology (Ireland), 2001, pp. 89-93. |
Coats, et al, “The Potential Impact of Percutaneous Pulmonary Valve Stent Implantation on Right Ventricular Outflow Tract Re-Intervention,” European Journal of Cardio-Thoracic Surgery (England), Apr. 2005, pp. 536-543. |
Cribier, A. et al, “Percutaneous Transcatheter Implantation of an Aortic Valve Prosthesis for Calcific Aortic Stenosis: First Human Case Description,” Circulation (2002) 3006-3008. |
Davidson et al., “Percutaneous therapies for valvular heart disease,” Cardiovascular Pathology 15 (2006) 123-129. |
Hanzel, et al., “Complications of percutaneous aortic valve replacement: experience with the Criber-Edwards™ percutaneous heart valve,” EuroIntervention Supplements (2006), 1 (Supplement A) A3-A8. |
Khambadkone, “Nonsurgical Pulmonary Valve Replacement: Why, When, and How?” Catheterization and Cardiovascular Interventions—Official Journal of the Society for Cardiac Angiography & Interventions (United States), Jul. 2004, pp. 401-408. |
Khambadkone, et al, “Percutaneous Implantation of Pulmonary Valves,” Expert Review of Cardiovascular Therapy (England), Nov. 2003, pp. 541-548. |
Khambadkone, et al, “Percutaneous Pulmonary Valve Implantation: Early and Medium Term Results,” Circulation 108 (17 Supplement), Oct. 28, 2003, p. IV-375. |
Lutter, et al, “Percutaneous Aortic Valve Replacement: An Experimental Study. 1. Studies on Implantation,” The Journal of Thoracic and Cardiovascular Surgery, Apr. 2002, pp. 768-776. |
Lutter, et al, “Percutaneous Valve Replacement: Current State and Future Prospects,” Annals of Thoracic Surgery (Netherlands), Dec. 2004, pp. 2199-2206. |
Medtech Insight, “New Frontiers in Heart Valve Disease,” vol. 7, No. 8 (2005). |
Palacios, “Percutaneous Valve Replacement and Repair, Fiction or Reality?” Journal of American College of Cardiology, vol. 44, No. 8 (2004) pp. 1662-1663. |
Pasupati et al., “Transcatheter Aortic Valve Implantation Complicated by Acute Structural Valve Failure Requiring Immediate Valve in Valve Implantation,” Heart, Lung and Circulation 2010; doi:10.1016/j.hlc.2010.05.006. |
Pelton et al., “Medical Uses of Nitinol,” Materials Science Forum vols. 327-328, pp. 63-70 (2000). |
Ruiz, “Transcathether Aortic Valve Implantation and Mitral Valve Repair: State of the Art,” Pediatric Cardiology, vol. 26, No. 3 (2005). |
Webb, et al., “Percutaneous Aortic Valve Implantation Retrograde from the Femoral Artery,” Circulation (2006), 113;842-850. |
Expert report of Dr. Nigel Buller, dated Jan. 12, 2009, Edwards' United Kingdom action for invalidity, Claim No. HC 08CO0934 (83 pages). |
Expert report of Dr. Nigel Buller, non-confidential annex—infringement, dated Jan. 12, 2009, Edwards' United Kingdom action for invalidity, Claim No. HC 08CO0934 (12 pages). |
Expert report of Dr. Rodolfo Quijano, dated Jan. 9, 2009, Edwards' LifeSciences v. Cook Biotech Incorporated, United Kingdom action for invalidity, Claim No. HC 08CO0934 (18 pages). |
First Expert report of Prof. David Williams, dated Jan. 12, 2009, Edwards' United Kingdom action for invalidity, Claim No. HC 08CO0934 (41 pages). |
Pavcnik et al., “Aortic and venous valve for percutaneous insertion,” Min. Invas. Ther. & Allied Techol. 2000, vol. 9, pp. 287-292. |
First Expert report of Dr. Nigel Person Buller (30 pages), Corevalve, Inc. v. Edwards Lifesciences AG and Edwards Lifesciences PVT, Inc., High Court of Justice—Chancery Division Patents Court, United Kingdom, Case No. HC-07-C01243. |
Number | Date | Country | |
---|---|---|---|
20100023120 A1 | Jan 2010 | US |
Number | Date | Country | |
---|---|---|---|
61125203 | Apr 2008 | US |